Successful percutaneous balloon mitral valvuloplasty in a patient with left atrial thrombus: A case report

Georges Nseir, Tak Kwan, Mahandra Mandawat, Alan Feit, Luther T. Clark

Research output: Contribution to journalArticle

Abstract

Percutaneous balloon mitral valvuloplasty (PBMV) described by Inoue et al, is a safe FDA (Food and Drug Administration) approved procedure in patients with severe mitral stenosis. One of the contraindications of the procedure is presence of a left atrial thrombus; however, it has been reported that intense warfarin therapy may led to dissolution of the thrombus. The authors report a patient who was referred for PBMV and was found to have a left atrial thrombus. After intense warfarin therapy, successful PBMV was undertaken without complications.

Original languageEnglish (US)
Pages (from-to)255-259
Number of pages5
JournalAngiology
Volume50
Issue number3
DOIs
StatePublished - Mar 1999

Fingerprint

Balloon Valvuloplasty
Thrombosis
Warfarin
Mitral Valve Stenosis
United States Food and Drug Administration
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Successful percutaneous balloon mitral valvuloplasty in a patient with left atrial thrombus : A case report. / Nseir, Georges; Kwan, Tak; Mandawat, Mahandra; Feit, Alan; Clark, Luther T.

In: Angiology, Vol. 50, No. 3, 03.1999, p. 255-259.

Research output: Contribution to journalArticle

Nseir, Georges ; Kwan, Tak ; Mandawat, Mahandra ; Feit, Alan ; Clark, Luther T. / Successful percutaneous balloon mitral valvuloplasty in a patient with left atrial thrombus : A case report. In: Angiology. 1999 ; Vol. 50, No. 3. pp. 255-259.
@article{0635c7ee62a24614a5bd1f53582a77e9,
title = "Successful percutaneous balloon mitral valvuloplasty in a patient with left atrial thrombus: A case report",
abstract = "Percutaneous balloon mitral valvuloplasty (PBMV) described by Inoue et al, is a safe FDA (Food and Drug Administration) approved procedure in patients with severe mitral stenosis. One of the contraindications of the procedure is presence of a left atrial thrombus; however, it has been reported that intense warfarin therapy may led to dissolution of the thrombus. The authors report a patient who was referred for PBMV and was found to have a left atrial thrombus. After intense warfarin therapy, successful PBMV was undertaken without complications.",
author = "Georges Nseir and Tak Kwan and Mahandra Mandawat and Alan Feit and Clark, {Luther T.}",
year = "1999",
month = "3",
doi = "10.1177/000331979905000311",
language = "English (US)",
volume = "50",
pages = "255--259",
journal = "Angiology",
issn = "0003-3197",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Successful percutaneous balloon mitral valvuloplasty in a patient with left atrial thrombus

T2 - A case report

AU - Nseir, Georges

AU - Kwan, Tak

AU - Mandawat, Mahandra

AU - Feit, Alan

AU - Clark, Luther T.

PY - 1999/3

Y1 - 1999/3

N2 - Percutaneous balloon mitral valvuloplasty (PBMV) described by Inoue et al, is a safe FDA (Food and Drug Administration) approved procedure in patients with severe mitral stenosis. One of the contraindications of the procedure is presence of a left atrial thrombus; however, it has been reported that intense warfarin therapy may led to dissolution of the thrombus. The authors report a patient who was referred for PBMV and was found to have a left atrial thrombus. After intense warfarin therapy, successful PBMV was undertaken without complications.

AB - Percutaneous balloon mitral valvuloplasty (PBMV) described by Inoue et al, is a safe FDA (Food and Drug Administration) approved procedure in patients with severe mitral stenosis. One of the contraindications of the procedure is presence of a left atrial thrombus; however, it has been reported that intense warfarin therapy may led to dissolution of the thrombus. The authors report a patient who was referred for PBMV and was found to have a left atrial thrombus. After intense warfarin therapy, successful PBMV was undertaken without complications.

UR - http://www.scopus.com/inward/record.url?scp=0033062986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033062986&partnerID=8YFLogxK

U2 - 10.1177/000331979905000311

DO - 10.1177/000331979905000311

M3 - Article

C2 - 10088806

AN - SCOPUS:0033062986

VL - 50

SP - 255

EP - 259

JO - Angiology

JF - Angiology

SN - 0003-3197

IS - 3

ER -